Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Chr. Hansen Holding Director's Dealing 2018

Nov 2, 2018

3357_rns_2018-11-02_425bc7d6-8a20-4a09-a54f-eaa30b2a5803.html

Director's Dealing

Open in viewer

Opens in your device viewer

Managers’ transactions

Managers’ transactions

Company Announcement No. 20/2018

November 2, 2018

For further information please contact:

Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250

Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384

About Chr. Hansen

Chr. Hansen is a leading global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed and plant protection. Our product innovation is based on more than 30,000 microbial strains – we like to refer to them as “good bacteria.” Our solutions enable food manufacturers to produce more with less – while also reducing the use of chemicals and other synthetic additives – which makes our products highly relevant in today’s world. We have been delivering value to our partners – and, ultimately, end consumers worldwide – for more than 140 years. We are proud that more than 1 billion people consume products containing our natural ingredients every day.

Attachment